NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In
Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational
UT Board Announces Support for MD Anderson Tenure System
Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals
In Brief: ESMO Names Annual Award Winners
Drugs and Targets: Akynzeo approved for chemotherapy-related nausea
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored










